Skip to main content
. 2015 Aug 11;6(25):20885–20901. doi: 10.18632/oncotarget.4928

Figure 2. Kaplan-Meier survival analysis by histological grade, age, histological type, IDH1/2 mutation, 1p/19q codeletion, TERTp mutation and EGFR amplification.

Figure 2

Longer overall survival was associated with grade II gliomas a. patients at 50 years or younger b. oligodendroglial or oligoastrocytic tumors c. IDH1/2 mutated gliomas d. 1p/19q codeleted gliomas e. and EGFR non-amplified gliomas g. TERTp mutated gliomas trended to longer overall survival f. OS, overall survival; mut, mutant; wt, wild-type.